About Shweta Kumari
Shweta's profound interest in financial research and quantitative analysis led her to pursue a career as an investment analyst. She uses her knowledge to help retail investors make educated investment decisions.
Shweta graduated with a bachelor's degree in accounting and finance and is currently pursuing the Chartered Accountancy course.
Recent Articles By Shweta Kumari
3 Top Financial Stocks Paying Juicy Dividends
The recent rate cuts from the Federal Reserve are poised to create a ripple effect across the financial sector, particularly for dividend-paying stocks. In light of this, dividend-seeking investors might want to consider investing in companies like Visa (V), Mastercard Inc. (MA), and American Express (AXP), which not only have large cash reserves but have also proven resilient through various market conditions. Read on…
3 Tech Stocks Under $20 With High Upside Potential
As tech stocks continue to gain momentum, many investors are eyeing opportunities in the sector, especially after the Fed’s recent rate cut. If you’re looking to capitalize on this trend, budget-friendly stocks like Hewlett Packard Enterprise (HPE), UiPath (PATH), and N-able (NABL), all trading under $20, could offer significant upside potential. Learn more…
3 Genomics Stocks Transforming Healthcare
Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As this field rapidly evolves, investing in fundamentally sound genomics stocks like Regeneron Pharmaceuticals (REGN), Alnylam Pharmaceuticals (ALNY), and Illumina (ILMN) could be beneficial. Read more…
Can Constellation Energy Shine Even Brighter After a 72% YTD Surge?
Shares of Constellation Energy (CEG) have surged over 72% year-to-date, significantly outperforming the broader market. In this article, we’ll take a closer look at what powered the nuclear energy company’s strong performance and assess whether it has the potential to shine brighter. Read on…
3 High-Dividend Pharma Blue Chips That Are on Sale Right Now
With the Federal Reserve potentially cutting interest rates for the first time in over four years, uncertainty looms in the market. Amid this backdrop, it could be wise to scoop up the shares of fundamentally sound pharma stocks like AbbVie (ABBV), Novartis (NVS), and Pfizer (PFE), which are not just attractive due to their high dividends but are also trading at discounts. Keep reading…
3 Top Infrastructure ETFs to Buy as Projects Ramp Up
With infrastructure spending on the rise, now could be an opportune time to invest in top infrastructure ETFs like Global X U.S. Infrastructure Development (PAVE), iShares Global Infrastructure (IGF), and iShares U.S. Infrastructure (IFRA), each poised to benefit from this booming industry. Learn more…
3 European Stocks to Buy as the Continent’s Economy Recovers
As Europe navigates a complex landscape of slowing inflation, stable employment, and modest GDP growth, it may be an opportune time for investors to consider investing in quality stocks like Novo Nordisk (NVO), SAP SE (SAP), and Novartis (NVS), which are poised to capitalize on the continent’s recovery. Read on…
3 Small-Cap Energy Stocks With Big Upside Potential
With the Federal Reserve expected to lower interest rates and a cautiously optimistic outlook for global oil demand, it could be wise to consider investing in quality small-cap energy stocks VAALCO Energy (EGY), Obsidian Energy (OBE), Adams Resources & Energy (AE), each with upside potential exceeding 60%. Read more…
3 High-Quality Retail Stocks Trading at a Discount
Thanks to resilience in consumer spending and the rapid evolution of technology, the retail sector is rising. Hence, it could be an opportune time to invest in high-quality discounted retail stocks such as Target Corp. (TGT), Kroger (KR), and Albertsons Companies (ACI). Read on…